Rhythm Pharmaceuticals因报告出现额外竞标者而上涨 (RYTM:NASDAQ)
· seekingalpha.com
Rhythm Pharmaceuticals股价飙升，据报道在阿斯利康近100亿美元收购要约后又出现第二个竞标者。
Rhythm Pharmaceuticals (RYTM) rose 4.2% amid a report of a second bidder for the biotech company.
One of the world's largest pharmaceutical companies is specul...